Moderna and Merck said Wednesday their experimental mRNA cancer vaccine successfully reduced recurrence of melanoma, and ...
If ongoing studies in other cancers produce similar results, the technology could influence far more than cancer care itself.
BioNTech, a former pioneer of mRNA cancer vaccines, was part of a broad rally Wednesday. Leerink analysts don’t expect the ...
After demand for its COVID-19 shots plummeted, its new treatment for melanoma has reversed the Mass. company’s fortunes.
Result in high-risk patients validates decades of research into mRNA-based therapeutic cancer vaccines.
Moderna shares more than doubled Wednesday after it announced initial results from a study of an experimental cancer ...
The U.S. national debt has surpassed $40 trillion for the first time, marking a staggering new milestone in the country’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results